Therapeutic Cancer Vaccine Boosts Survival for People Battling Advanced Melanoma
MONDAY, April 17, 2023 (HealthDay News) — An experimental vaccine whipped up to specifically target a melanoma patient’s tumor cells significantly reduces the likelihood of the cancer recurring, early clinical trial data show. Each dose of the vaccine, called mRNA-4157/V940, is crafted based on the unique genetics of an individualContinue Reading










